首页 > 专栏 > The Lancet The Lancet 共 421 条资讯 [Correspondence] Underuse of neuromodulation in depression care 2026-06-28 08:37:00 [Correspondence] Smoking rates: when should harm-reduction evidence be updated? 2026-06-28 08:37:00 [Perspectives] Beyond the battlefield: war and global health security 2026-06-28 08:37:00 [Correspondence] Cultural calibration is needed in global mental disorder burden estimates 2026-06-28 08:37:00 [Obituary] Roger Detels 2026-06-28 08:37:00 [Perspectives] Temporal rationing: a man with gastric cancer in Colombia 2026-06-28 08:37:00 [Correspondence] Cultural calibration is needed in global mental disorder burden estimates – Authors’ reply 2026-06-28 08:37:00 [Perspectives] John Wong: making an impact on population health at scale 2026-06-28 08:37:00 [Comment] 21st century global threats to health are not what you think 2026-06-28 08:37:00 [The Lancet Commissions] The Lancet Commission on 21st century global threats to health 2026-06-28 08:37:00 [Review] Addressing threats to future global health—what is the right timeframe? 2026-06-28 08:37:00 [Editorial] Rethinking threats to human survival 2026-06-28 08:37:00 [Correspondence] Bundibugyo virus: coordinating a cross-border response 2026-06-28 08:37:00 [Articles] Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial 2026-06-28 08:37:00 [Articles] 8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India 2026-06-28 08:37:00 [Comment] A novel and effective treatment for fibrodysplasia ossificans progressiva 2026-06-28 08:37:00 [Articles] Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial 2026-06-28 08:37:00 [Comment] The WHS Academic Alliance–Lancet Commission on academic responsibility for trust in science and societal change 2026-06-28 08:37:00 [Articles] Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial 2026-06-28 08:37:00 [Department of Error] Department of Error 2026-06-28 08:37:00 « 上一页1…34567…22下一页 » 相关分类 The Lancet ScienceDirect Publication: The Lancet ScienceDirect Publication: The Lancet Oncology The Lancet Child & Adolescent Health The Lancet Diabetes & Endocrinology The Lancet Digital Health The Lancet Gastroenterology & Hepatology The Lancet Global Health The Lancet HIV The Lancet Haematology The Lancet Healthy Longevity The Lancet Infectious Diseases The Lancet Microbe The Lancet Neurology The Lancet Oncology The Lancet Planetary Health The Lancet Psychiatry